About Us

Medrobotics Corporation (formerly Cardiorobotics, Inc.) is a Delaware "C" Corporation, originally formed in 2005 (as Innovention Technologies, LLC) by the inventors of our technology. They are Howie Choset, PhD, a tenured Associate Professor of Robotics at Carnegie Mellon University, Dr. Marco Zenati, a cardiothoracic surgeon and Professor of Surgery at Harvard Medical School, and Dr. Alon Wolf, Associate Professor at Technion University in Israel. Dr. Zenati was on the medical faculty of the University of Pittsburgh at the time he and Drs. Choset and Wolf developed the first generation medical "snake robotics" platform in-licensed by the Company. Dr. Choset and Dr. Zenati continue to remain involved in technology development at the Company.

Medrobotics has an exclusive worldwide license for its technology from Carnegie Mellon University as well as additional robust development of its own intellectual property portfolio. The Company has an operational facility in New England, with partners located throughout the United States.



Medrobotics Announces Launch of the Flex® Retractor More

Surgeons Complete Cancer Surgery with Medrobotics’ Flex® System in Front of a Live Audience at Head and Neck Surgical Course at University Hospital of Marburg More

Surgeons of the University Hospital Essen Complete World’s First Robotic-Assisted Cancer Surgery with Medrobotics' Flex® System More

University Hospital Dinant Godinne-UCL Namur Completes World’s First Robotic-Assisted Surgery with Medrobotics‘ Flex® System More

Medrobotics Closes $26 Million Series E Financing More

Medrobotics Corporation Receives CE Mark for the Flex® System, Mar. 18, 2014, More

Medrobotics Appoints Russell M. Singleton, Ph.D., as Senior Vice-President R&D, Mar. 17, 2014 More

Medrobotics Appoints Thomas F. Patzelt Vice-President Marketing, Jan. 2, 2014 More

Medrobotics Gains ISO 13485: 2003 Certification for the Design, Manufacture, Service and Distribution of the Flex™ System, Nov. 3, 2013 More

Medrobotics Closes On $10 Million Financing From Hercules, March 22, 2013 More

Medrobotics Appoints Richard S. Walsh Vice-President Global Sales, Feb. 4, 2013 More

Medrobotics Completes $33.6 Million Series D Financing: Company Prepares for Commercialization of the Ground-Breaking Flex™ System in Otolaryngology, Dec. 20, 2012

Medrobotics Corporation. ©2014. All rights reserved.   Legal Information  •  Privacy Policy